MBRX

Moleculin Biotech Inc

Jun 23 • 04:00PM ET

2.75

-0.37 -11.86 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: BLRX CYCN ERNA GDTC GNTA GTBP ICU INTS RKTO TOVX

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-28.04	Insider Own	0.83%	Shs Outstand	5.34M	Perf Week	1.48%
Market Cap	14.68M	Forward P/E	-	EPS next Y	-3.84	Insider Trans	0.00%	Shs Float	5.29M	Perf Month	15.06%
Enterprise Value	4.69M	PEG	-	EPS next Q	-1.54	Inst Own	3.21%	Short Float	15.67%	Perf Quarter	30.95%
Income	-32.20M	P/S	-	EPS this Y	82.01%	Inst Trans	1.13%	Short Ratio	4.30	Perf Half Y	-28.20%
Sales	0.00M	P/B	0.97	EPS next Y	24.84%	ROA	-136.70%	Short Interest	0.83M	Perf YTD	-16.92%
Book/sh	2.85	P/C	1.42	EPS next 5Y	49.99%	ROE	-398.45%	52W High	24.00 -88.54%	Perf Year	-59.84%
Cash/sh	1.93	P/FCF	-	EPS past 3/5Y	57.89% 46.71%	ROIC	-197.37%	52W Low	1.79 53.63%	Perf 3Y	-98.64%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.66% 8.42%	Perf 5Y	-99.80%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	80.65%	Oper. Margin	-	ATR (14)	0.22	Perf 10Y	-99.98%
Dividend Ex-Date	-	Quick Ratio	1.38	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	54.54	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.38	EPS Q/Q	79.43%	SMA20	4.05%	Beta	1.72	Target Price	21.00
Payout	-	Debt/Eq	0.02	Sales Q/Q	-	SMA50	9.23%	Rel Volume	58.06	Prev Close	3.12
Employees	17	LT Debt/Eq	0.01	Earnings	May 15 BMO	SMA200	-51.21%	Avg Volume	192.79K	Price	2.75
IPO	Jun 02, 2016	Option/Short	No / No	EPS/Sales Surpr.	-51.72% -	Trades		Volume	11,192,990	Change	-11.86%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)